# Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation

> **NCT00065507** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 195 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DRUG:** Entecavir (ETV)
- **DRUG:** Adefovir (ADV)

## Key facts

- **NCT ID:** NCT00065507
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** 2008-10
- **Final completion:** 2013-05
- **Target enrollment:** 195 (ACTUAL)
- **Last updated:** 2013-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00065507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00065507, "Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00065507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*